📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Inhibitory killer cell immunoglobulin-like receptors strengthen CD8+ T cell-mediated control of HIV-1, HCV, and HTLV-1. (2018)

First Author: Boelen L

Attributed to: Systematic characterisation of the HCMV pathogenicity domain spontaneously lost from commonly used passaged strains funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/sciimmunol.aao2892

PubMed Identifier: 30413420

Publication URI: http://europepmc.org/abstract/MED/30413420

Type: Journal Article/Review

Volume: 3

Parent Publication: Science immunology

Issue: 29

ISSN: 2470-9468